Formulation and clinical evaluation of silymarin pluronic-lecithin organogels for treatment of atopic dermatitis

References

• DarsowURaapUStänderSRCarstensEAkiyamaTItch: Mechanisms and TreatmentBoca RatonCRC Press2014832836
   Google Scholar
• RingJPrzybillaBRuzickaTHandbook of atopic eczema2nd edNew YorkSpringer-Verlag Berlin Heidelberg2006
   Google Scholar
• FriedmmanPSHoldenCAAtopic dermatitisBurnsTBreathnachSCoxNGriffithsCRook’s Textbook of Dermatology7th edOxford, EnglandBlackwell Sciences2008755786
   Google Scholar
• CharmanCClinical evidence: atopic eczemaBMJ199931871981600160410364122
   PubMedGoogle Scholar
• SudilovskyAMuirJGBocoboFCA comparison of single and multiple applications of halcinonide creamInt J Dermatol19812096096137030988
   PubMed Web of Science ®Google Scholar
• DarsowULübbeJTaïebAPosition paper on diagnosis and treatment of atopic dermatitisJ Eur Acad Dermatol Venereol200519328629515857453
   PubMed Web of Science ®Google Scholar
• HaeckIMRouwenTJMikLTBruin-WellerMSBruijnzeel-KoomenCATopical corticosteroids in atopic dermatitis and the risk of glaucoma and cataractsJ Am Acad Dermatol201164227528121122943
   PubMed Web of Science ®Google Scholar
• HajarTLeshemYAHanifinJMA systematic review of topical corticosteroid withdrawal (“steroid addiction”) in patients with atopic dermatitis and other dermatosesJ Am Acad Dermatol2015723541e549e.e225592622
   PubMed Web of Science ®Google Scholar
• O’HaraMKieferDFarrellKKemperKA review of 12 commonly used medicinal herbsArch Fam Med1998765235369821826
   PubMedGoogle Scholar
• ZhaoJLahiri-ChatterjeeMSharmaYAgarwalRInhibitory effect of a flavonoid antioxidant silymarin on benzoyl peroxide-induced tumor promotion, oxidative stress and inflammatory responses in SENCAR mouse skinCarcinogenesis200021481181610753220
   PubMed Web of Science ®Google Scholar
• GazakRWalterovaDKrenVSilybin and silymarin – new and emerging applications in medicineCurr Med Chem200714331533817305535
   PubMed Web of Science ®Google Scholar
• SinghRPAgarwalRCosmeceuticals and SilibininClin Dermatol200927547948419695480
   PubMed Web of Science ®Google Scholar
• DehmlowCErhardJde GrootHInhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibininHepatology19962347497548666328
   PubMed Web of Science ®Google Scholar
• RasulANaveedAAliAAssessment of anti erythmic and skin whitening effects of milk thistle extractAfrican Journal of Pharmacy and Pharmacology20115202023062309
   Google Scholar
• SvobodováAWalterováDPsotováJInfluence of silymarin and its flavonolignans on H(2)O(2)-induced oxidative stress in human keratinocytes and mouse fibroblastsBurns200632897397917011711
   PubMed Web of Science ®Google Scholar
• TokluHZTunalı-AkbayTErkanlGYukselMErcanFSenerGSilymarin, the antioxidant component of Silybum marianum, protects against burn-induced oxidative skin injuryBurns200733790891617521818
   PubMed Web of Science ®Google Scholar
• Ashkani-EsfahaniSEmamiYEsmaeilzadehESilymarin enhanced fibroblast proliferation and tissue regeneration in full thickness skin wounds in rat models; a stereological studyJournal of the Saudi Society of Dermatology & Dermatologic Surgery2013171712
   Google Scholar
• HanMHYoonWKLeeHTopical application of silymarin reduces chemical-induced irritant contact dermatitis in BALB/c miceInt Immunopharmacol20077131651167817996674
   PubMed Web of Science ®Google Scholar
• Becker-SchiebeMMengsUSchaeferMBulittaMHoffmannWTopical use of a silymarin-based preparation to prevent radiodermatitis: results of a prospective study in breast cancer patientsStrahlenther Onkol2011187848549121786113
   PubMed Web of Science ®Google Scholar
• GilletALecomteFHubertPDucatEEvrardBPielGSkin penetration behaviour of liposomes as a function of their compositionEur J Pharm and Biopharm2011791435321272638
   PubMed Web of Science ®Google Scholar
• JosefEZilbermanMBianco-PeledHComposite alginate hydrogels: An innovative approach for the controlled release of hydrophobic drugsActa Biomater20106124642464920601237
   PubMed Web of Science ®Google Scholar
• SpadaGGaviniECossuMRassuGCartaAGiunchediPEvaluation of the effect of hydroxypropyl-β-cyclodextrin on topical administration of milk thistle extractCarbohydr Polym2013921404723218263
   PubMed Web of Science ®Google Scholar
• KumarRKatareOPLecithin organogels as a potential phospholipid structured system for topical drug delivery: a reviewAAPS Pharm-SciTech200562E298E310
   PubMed Web of Science ®Google Scholar
• ParsaeeSSarboloukiMNParniapourMIn-vitro release of diclofenac dethylammnium from lipid-based formulationsInt J Pharm2002241118519012086734
   PubMedGoogle Scholar
• PeinzesTCsoikaIErosIRheological analysis of the structural properties effecting the percutaneous absorption and stability in pharmaceutical organogelsRheol Acta200443457463
   Web of Science ®Google Scholar
• BalataGEl NahasHMRadwanSPropolis organogel as a novel topical delivery system for treating woundsDrug Deliv2014211556124295500
   PubMed Web of Science ®Google Scholar
• SurjyanarayanMSnigdhaSMKrutikaKSLecithin stabilized organogel: design and development for topical application of clobetasol propionateInt J Pharm Tech Res20102211331138
   Google Scholar
• StationwalaRPatidarAMainPTransdermal delivery of Iornoxicam from pluronic lecithin organogelInt J Chem Pharm Sci2011223237
   Google Scholar
• PiscitelliSCFormentiniEBursteinAHAlfaroRJagannathaSFalloonJEffect of milk thistle on the pharmacokinetics of indinavir in healthy volunteersPharmacotherapy200222555155612013352
   PubMed Web of Science ®Google Scholar
• JohnsonVJHeQOsuchowskiMFSharmaRPPhysiological responses of a natural antioxidant flavonoid mixture, silymarin, in BALB/c mice: III. Silymarin inhibits T-lymphocyte function at low doses but stimulates inflammatory processes at high dosesPlanta Med2003691444912567278
   PubMed Web of Science ®Google Scholar
• KangJSYoonWKHanMHInhibition of atopic dermatitis by topical application of silymarin in NC/Nga miceInt Immunopharmacol20088101475148018593606
   PubMed Web of Science ®Google Scholar
• AlmeidaHAmaralMHLobaoPLoboJMPluronic® F-127 and Pluronic Lecithin Organogel (PLO): main features and their applications in topical and transdermal administration of drugsJ Pharm Pharm Sci201215459260523106961
   PubMed Web of Science ®Google Scholar
• BhatiaASinghBRazaKWadhwaSKatareOTamoxifen-loaded lecithin organogel (LO) for topical application: Development, optimization and characterizationInt J Pharm20134441–2475923353077
   PubMedGoogle Scholar